The Globe and Mail | May 31, 2024
UBC professor Sriram Subramaniam, meanwhile, will lead a project in partnership with local drug developers and pharmaceutical giant GSK, using cryo-electron microscopy and AI-enabled drug discovery to build a bank of antibody treatments for pathogens with pandemic-causing potential. “The total focus is on product that can be manufactured at scale to go into humans,” Dr. Subramaniam said.